.Pharmacolibrary.Drugs.ATC.N.N07BA01_1 .Pharmacolibrary.Drugs.ATC.N.N07BA01_1| name: | Nicotine_1 |
| ATC code: | N07BA01_1 | route: | transdermal |
| n-compartments | 2 |
Nicotine is a potent parasympathomimetic alkaloid found in tobacco. It acts as an agonist at nicotinic acetylcholine receptors in the central and peripheral nervous system. Clinically, nicotine has been used as an aid in smoking cessation therapies in the form of patches, gums, lozenges, nasal sprays, and inhalers. It remains approved for use in various nicotine replacement therapies.
Healthy adult volunteer smokers administered nicotine via transdermal patch (nicotine replacement therapy).
Olsson Gisleskog, PO, et al., & Soons, PA (2021). Nicotine Population Pharmacokinetics in Healthy Smokers After Intravenous, Oral, Buccal and Transdermal Administration. Clinical pharmacokinetics 60(4) 541–561. DOI:10.1007/s40262-020-00960-5 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33354734
Linakis, MW, et al., & Sherwin, CMT (2017). Population pharmacokinetic model of transdermal nicotine delivered from a matrix-type patch. British journal of clinical pharmacology 83(12) 2709–2717. DOI:10.1111/bcp.13393 PUBMED:https://pubmed.ncbi.nlm.nih.gov/28771779
Sobue, S, et al., & Irie, S (2005). Effect of application sites and multiple doses on nicotine pharmacokinetics in healthy male Japanese smokers following application of the transdermal nicotine patch. Journal of clinical pharmacology 45(12) 1391–1399. DOI:10.1177/0091270005282632 PUBMED:https://pubmed.ncbi.nlm.nih.gov/16291714